News

In December 2006, Halozyme entered into an agreement with Roche to apply Halozyme’s Enhanze technology to Roche’s biological therapeutic compounds. Under the terms of the agreement, Roche paid

This is the second licensing agreement between the two companies concerning Merrion’s Gipet technology – the first agreement for the development of oral insulin analogs was signed in

In his most recent endeavor, Faulkner served as president, chief executive officer (CEO) and member of the board of directors of Digene Corporation, a Nasdaq-traded company prior to

“The opportunity that lies in front of Abraxis BioScience is enormous and is a result of the validated science underlying the company’s proprietary nab(R) technology in the clinical

“bioMérieux performed well in the fourth quarter in a much more challenging economic environment,” commented chief executive officer Stéphane Bancel. “Full-year sales rose 7.5% like-for-like, meeting the targets

This new facility, Abbott’s first pharmaceutical R&D site in Southeast Asia, will conduct stability studies, including studies on active pharmaceutical ingredients and novel formulations, to support global regulatory

In this role, Mr Pred is responsible for overseeing all US manufacturing operations. Most recently, Mr Pred led all manufacturing in a multi-plant operation for vaccine production for

In her role, Ms Carol will lead the client service division in delivering client account management, developing and implementing growth strategies, and contributing to sales and marketing efforts

OmniDROP is the first bi-directional HIPAA-compliant peer-to-peer drop box communications software utility for Windows and Apple systems and is specifically designed to facilitate effective communications between physicians, medical